KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elevance Health (ELV) EBIT (2016 - 2025)

Elevance Health (ELV) has disclosed EBIT for 17 consecutive years, with $493.0 million as the latest value for Q4 2025.

  • Quarterly EBIT fell 6.45% to $493.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Dec 2025, up 6.97% year-over-year, with the annual reading at $2.2 billion for FY2025, 6.97% up from the prior year.
  • EBIT for Q4 2025 was $493.0 million at Elevance Health, down from $625.0 million in the prior quarter.
  • The five-year high for EBIT was $625.0 million in Q3 2025, with the low at $291.0 million in Q1 2021.
  • Average EBIT over 5 years is $446.6 million, with a median of $440.5 million recorded in 2023.
  • The sharpest move saw EBIT skyrocketed 601.75% in 2021, then dropped 6.45% in 2025.
  • Over 5 years, EBIT stood at $352.0 million in 2021, then increased by 5.97% to $373.0 million in 2022, then soared by 41.82% to $529.0 million in 2023, then dropped by 0.38% to $527.0 million in 2024, then decreased by 6.45% to $493.0 million in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at $493.0 million, $625.0 million, and $486.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.